Cardiomyopathy Associated with Antiretroviral Therapy in Patients with HIV Infection: A Report of Six Cases

Abstract

Brief Reports15 February 1992Cardiomyopathy Associated with Antiretroviral Therapy in Patients with HIV Infection: A Report of Six CasesAhvie Herskowitz, MD, Sharon B. Willoughby, MA, Kenneth L. Baughman, MD, Steven P. Schulman, MD, John D. Bartlett, MDAhvie Herskowitz, MD, Sharon B. Willoughby, MA, Kenneth L. Baughman, MD, Steven P. Schulman, MD, John D. Bartlett, MDAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-116-4-311 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptSymptomatic congestive heart failure has been described as part of the spectrum of human immunodeficiency virus (HlV)-related cardiac disease (1-3). Echocardiographic studies have further documented dilated cardiomyopathy in 11% to 22% of HIV-infected adults (4, 5).The direct etiologic role of HIV infection in cardiomyopathy is controversial. In-situ hybridization studies have failed to show HIV genomic material in endomyocardial biopsy samples taken from patients with HIV-associated myocarditis and clinically established congestive heart failure (6). Rare infected myocytes have, however, been shown using similar techniques in autopsy specimens from patients without heart disease (7). Other etiologies should be considered, such as...References1. Cohen I, Anderson D, Virmani R, Reen B, Macher A, and Sennesh J. Congestive cardiomyopathy in association with the acquired immunodeficiency syndrome. N Engl J Med. 1986;315:628-30. CrossrefMedlineGoogle Scholar2. Reilly J, Cunnion R, Anderson D, O'Leary T, Simmons J, and Lane H. Frequency of myocarditis, left ventricular dysfunction and ventricular tachycardia in the acquired immune deficiency syndrome. Am J Cardiol. 1988;66:789-93. CrossrefGoogle Scholar3. Baroldi G, Corallo S, Moroni M, Repossini A, Mutinelli M, and Lazzarin A. Focal lymphocytic myocarditis in acquired immunodeficiency syndrome (AIDS): a correlative morphologic and clinical study in 26 consecutive fatal cases. J Am Coll Cardiol. 1988;12:463-9. CrossrefMedlineGoogle Scholar4. Corallo S, Mutinelli M, Moroni M, Lazzarin A, Celano V, and Repossini A. Echocardiography detects myocardial damage in AIDS: A prospective study in 102 patients. Eur Heart J. 1988;9:887-92. CrossrefMedlineGoogle Scholar5. Anderson D and Virmani R. Emerging patterns of heart disease in human immunodeficiency virus infection. Hum Pathol. 1990;21:253-9. CrossrefMedlineGoogle Scholar6. Beschorner W, Baughman K, Turnicky R, Hutchins G, Rowe S, and Kavanaugh-McHugh A. HIV-associated myocarditis. Pathology and immunopathology. Am J Pathol. 1990;137:1365-71. MedlineGoogle Scholar7. Grody W, Cheng L, and Lewis W. Infection of the heart by the human immunodeficiency virus. Am J Cardiol. 1990;66:203-6. CrossrefMedlineGoogle Scholar8. Lewis W, Papoian T, Gonzales B, Louie H, Kelly D, and Payne R. Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts. Lab Invest. 1991;65:228-36. MedlineGoogle Scholar9. Dalakas M, Illa I, Pezeshkpour G, Laukaitis J, Cohen B, and Griffin J. Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med. 1990;322:1098-105. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: Ahvie Herskowitz, MD; Sharon B. Willoughby, MA; Kenneth L. Baughman, MD; Steven P. Schulman, MD; John D. Bartlett, MDFrom The Johns Hopkins Hospital and School of Public Health and Hygiene, Baltimore, Maryland. For current author addresses, see end of text. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byAssessment of left ventricular diastolic function in children with HIV/AIDS attending a tertiary health Facility in Enugu, Nigeria: a Doppler echocardiographic studyImmune Dysregulation in Myocardial Fibrosis, Steatosis, and Heart Failure: Current Insights from HIV and the General PopulationA Study of Cardiovascular Manifestations in HIV Positive Patients and Their Association with the CD4 Cell CountEpidemiology, pathophysiology, and prevention of heart failure in people with HIVAcute myocarditis after switch to dolutegravirHeart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive ConsiderationsMechanisms of Cardiovascular Disease in the Setting of HIV InfectionCardiotoxicity and HIV/AIDS TherapyAssociation of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected PatientsCARDIOVASCULAR MANIFESTATIONS OF HIV INFECTED PATIENTS: RESULTS OF A SINGLE CENTRE STUDY FROM A TERTIARY CARE CENTREInfectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus InfectionRole of Mitochondrial RNA Polymerase in the Toxicity of Nucleotide Inhibitors of Hepatitis C VirusNucleoside analogue reverse transcriptase inhibitors (NRTIs)The Causes of HIV-Associated Cardiomyopathy: A Tale of Two WorldsHuman Immunodeficiency Virus and Heart Failure in Low- and Middle-Income CountriesThe duality of chemokines in heart failureA STUDY TO DETERMINE THE PREVALENCE OF CARDIAC DISEASE IN HIV POSITIVE PATIENTS IN A TERTIARY CARE HOSPITALHIV RELATED OPPORTUNISTIC INFECTIONS: A SYSTEM WISE APPROACHHIV Treatment and Associated Mitochondrial PathologyECMO in Myocarditis and Rare CardiomyopathiesHIV/AIDS Related Cardiac DiseasesCardiomyopathiesHIV and the heart: the impact of antiretroviral therapy: a global perspectiveManifestations, Mechanisms, and Treatment of HIV-Associated Cardiovascular DiseaseImpact of Highly Active Antiretroviral Therapy on paediatric Human Immunodeficiency Virus-associated left ventricular dysfunction within the Johannesburg teaching hospital complexSoluble mediators of inflammation in HIV and their implications for therapeutics and vaccine developmentWhat a Differential a Virus Makes: A Practical Approach to Thoracic Imaging Findings in the Context of HIV Infection???Part 2, Extrapulmonary Findings, Chronic Lung Disease, and Immune Reconstitution SyndromeCardiovascular complications of HIV infectionMyocarditis in CD8-Depleted SIV-Infected Rhesus Macaques after Short-Term Dual Therapy with Nucleoside and Nucleotide Reverse Transcriptase InhibitorsNucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNATransgenic mouse models of mitochondrial toxicity associated with HIV/AIDS and antiretroviralsPolymerase gamma disease through the agesA mechanistic view of human mitochondrial DNA polymerase γ: Providing insight into drug toxicity and mitochondrial diseaseCardiovascular Toxicities of Life-Saving Drugs: Antiviral TherapyEvidence-Based Decisions in Human Immunodeficiency Virus Infection and Cardiac DiseaseCardiotoxicity and HIV/AIDS TherapyANTIVIRAL DRUGS, INCLUDING IMMUNOGLOBULINS AND INTERFERONSCytotoxicological Analysis of a gp120 Binding Aptamer with Cross-Clade Human Immunodeficiency Virus Type 1 Entry Inhibition Properties: Comparison to Conventional AntiretroviralsCardiac MRI in Diagnosis of Myocardial Disease in HIV-Infected PatientsADVERSE CARDIOVASCULAR EFFECTS OF NON-CARDIOVASCULAR DRUGSMitochondrial DNA Impairment in Nucleoside Reverse Transcriptase Inhibitor-Associated CardiomyopathyAntigenic stimulation in the simian model of HIV infection yields dilated cardiomyopathy through effects of TNFαRight and left cardiac function in HIV-infected patients investigated using radionuclide ventriculography and brain natriuretic peptide: a 5-year follow-up studyMyocardial disease in human immunodeficiency virus (HIV) infection: a reviewCardiovascular Complications of HIV InfectionMitochondrial Dysfunction in AtherosclerosisCardiovascular Involvement in Acquired Immune Deficiency SyndromeMyocarditisCardiomyopathiesTreatment of Cardiovascular Manifestations of HIVSIV-Associated Myocarditis: Viral and Cellular Correlates of Inflammation SeverityStavudine, Didanosine, and ZalcitabineNucleoside analogue reverse transcriptase inhibitors (NRTIs)Cardiovascular Complications of Human Immunodeficiency Virus InfectionAn Overview of Mitochondrial Toxicity of Nucleoside Reverse Transcriptase Inhibitors Associated with HIV TherapyECHO ROUNDS Section Editor: Edmund Kenneth Kerut, M.D.: Echocardiographic Findings in HIV Disease and AIDSNucleoside Reverse Transcriptase Inhibitors, Mitochondrial Dna and Aids TherapyMitochondria Dysfunction in Cardiomyopathy and Heart FailureCardiac Manifestations in Human Immunodeficiency Virus InfectionAcute Reversible Heart Failure with Highly Active Antiretroviral TherapyMitochondrial dysfunction and nucleoside reverse transcriptase inhibitor therapy: experimental clarifications and persistent clinical questionsPathogenesis of HIV-associated heart diseaseMitochondrial DNA replication, nucleoside reverse-transcriptase inhibitors, and AIDS cardiomyopathyEchocardiography in HIV cardiac diseaseDefective mitochondrial DNA replication and NRTIs: pathophysiological implications in AIDS cardiomyopathyCardiac involvement in HIV infected people in Yaounde, CameroonUnderstanding the impact of mitochondrial defects in cardiovascular disease: A reviewIncidence of cardiac abnormalities in children with human immunodeficiency virus infection: The prospective P2 C2 HIV studyAnimal models of anti-HIV drugs exposure during pregnancyMitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?La mitocondria y el corazónMitochondrial toxicity associated with nucleoside reverse transcriptase inhibitor therapyCombined Antiretroviral Therapy Causes Cardiomyopathy and Elevates Plasma Lactate in Transgenic AIDS MicePathogenesis of HIV‐Associated CardiomyopathyDrugs and Cardiotoxicity in HIV and AIDSCoronary heart disease associated with the use of human immunodeficiency virus (HTV)-1 protease inhibitors: Report of four cases and reviewCardiovascular Manifestations of HIV InfectionMitochondrial DNA Depletion, Oxidative Stress, and Mutation: Mechanisms 0f Dysfunction from Nucleoside Reverse Transcriptase InhibitorsAlteraciones cardíacas en el paciente con infección crónica por el virus de la inmunodeficiencia humana tipo 1Cardiomyopathy in AIDS: A pathophysiological perspectiveFetal Mitochondrial Heart and Skeletal Muscle Damage in Erythrocebus patas Monkeys Exposed in Utero to 3'-Azido-3'-DeoxythymidineCardiac Dysfunction Occurs in the HIV-1 Transgenic Mouse Treated with ZidovudineDilated Cardiomyopathy Associated With Simian AIDS in Nonhuman PrimatesMolecular mechanism of the short-term cardiotoxicity caused by 2′,3′-dideoxycytidine (ddC): modulation of reactive oxygen species levels and ADP-ribosylation reactionsThe detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV diseaseCardiac Complications in Children With Human Immunodeficiency Virus InfectionIs Age a Contributory Factor of Mitochondrial Bioenergetic Decline and DNA Defects in Idiopathic Dilated Cardiomyopathy?PRIMARY CARE AND CASE MANAGEMENT OF PERSONS WITH HIV/AIDSZidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletionIncidence of Dilated Cardiomyopathy and Detection of HIV in Myocardial Cells of HIV-Positive PatientsAdverse effects of reverse transcriptase inhibitorsCardiac Involvement in the Acquired Immunodeficiency Syndrome: A Multicenter Clinical-Pathological StudyMitochondrial DNA Defects in CardiomyopathyCardiac Manifestations of HIV/AIDSPredictors of myocardial dysfunction in human immunodeficiency virus-infected patientsLeft ventricular dysfunction in human immunodeficiency virus (HIV)-infected patientsCardiac mitochondrial dysfunction and DNA depletion in children with hypertrophic cardiomyopathyHuman immunodeficiency virus infection after heart transplantation: Development of cardiomyopathy after long-term survivalAids treatment and the heat shock protein level in the gastrointestinal tractLeft ventricular dysfunction in infants and children infected with the human immunodeficiency virusHeart failure and cardiac disease in children with HIV infectionAids Treatment and the Heat Shock Protein Level in the Gastrointestinal TractAfectación cardíaca en el sidaCARDIAC INVOLVEMENT IN HIV INFECTIONHuman immunodeficiency virus type 1 infection of the heart in three infants with acquired immunodeficiency syndrome and sudden deathMyocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe.Clinical toxicity of antiretroviral nucleoside analogsThe Role of Antiretroviral Therapy in the Management of HIV Infection in WomenSélénium, virus et cardiomyopathieMyocardial atrophy in acquired immunodeficiency syndrome—associated wastingAIDS and the heart: Clinicopathologic assessmentEffect of zidovudine and didanosine treatment on heart function in children infected with human immunodeficiency virusCARDIOVASCULAR MANIFESTATIONS OF PEDIATRIC HIV INFECTIONCARDIOVASCULAR AND RENAL COMPLICATIONS OF HIV INFECTIONMitochondrial toxicity of antiviral drugsAnticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruriaFrequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infectionMycarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late-stage infection with human immunodeficiency virusLimitations of fractional shortening as an index of contractility in pediatric patients infected with human immunodeficiency virusIn vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infectionPrevalence of toxoplasma myocarditis in patients with the acquired immunodeficiency syndrome.Reversible cardiac dysfunction associated with foscarnet therapy for cytomegalovirus esophagitis in an AIDS patientPrevalence and incidence of left ventricular dysfunction in patients with human immunodeficiency virus infectionCardiac Structure and Function in HIV-Infected ChildrenAntiviral drugsCardiac Structure and Function in Children with Human Immunodeficiency Virus Infection Treated with ZidovudineDilated cardiomyopathy in a zidovudine-treated AIDS patientZidovudine: Five Years LaterGavin X. McLeod, MD, Scott M. Hammer, MDZidovudine/didanosine/dideoxycytidineCurrent status of therapy for human immunodeficiency virus type 1Mitochondria in Pediatric CardiologyMitochondrial Dysfunction and Nucleoside Reverse Transcriptase Inhibitor Therapy 15 February 1992Volume 116, Issue 4 Page: 311-313 Keywords Cardiomyopathies Heart failure HIV HIV infections Hygiene Immunology Infectious diseases Muscular dystrophies Myocarditis Prevention, policy, and public health ePublished: 1 December 2008 Issue Published: 15 February 1992 PDF downloadLoading ...